Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T4OT
|
|||
| Former ID |
DIB006517
|
|||
| Drug Name |
Zilascorb (2H)
|
|||
| Synonyms |
Zoxxoz
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Discontinued in Phase 2 | [1] | |
| Company |
Pronova BioPharma ASA
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H12O6
|
|||
| Canonical SMILES |
C1C(OC(O1)C2=CC=CC=C2)C3C(=C(C(=O)O3)O)O
|
|||
| InChI |
1S/C13H12O6/c14-9-10(15)12(16)19-11(9)8-6-17-13(18-8)7-4-2-1-3-5-7/h1-5,8,11,13-15H,6H2/t8-,11+,13?/m0/s1/i13D
|
|||
| InChIKey |
SWTGJCNCBUCXSS-GUFVNPKRSA-N
|
|||
| CAS Number |
CAS 122431-96-3
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Protein synthesis (hPRO synth) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001916) | |||
| REF 2 | Zilascorb(2H), a new reversible protein synthesis inhibitor: clinical study of an oral preparation. Anticancer Drugs. 1997 Mar;8(3):296-303. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.